Clinical Trial Update: Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating adalimumab in adult Japanese subjects with rheumatoid arthritis; the trial is completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2010-01-29